Bronnen:
- Hellerstedt BA, Vogelzang NJ, Kluger HM et al. Results of a Phase 2 Placebo-Controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non–Small-Cell Lung Carcinoma. Clinical Lung Cancer, 24 oktober 2018, https://doi.org/10.1016/j.cllc.2018.10.006